Oklahoma State Medical Association
OSMA CME Meeting
October 26, 2018
Embassy Suites Downtown Medical Center
741 N. Phillips Ave.
Oklahoma City, OK  73104

"The Crossroads Of Marijuana: Do It Right!”

The Oklahoma State Medical Association in collaboration with the Oklahoma State Board of Medical Licensure and Supervision, Osteopathic Founders Foundation, Oklahoma State Department of Health and PLICO a Med/Pro Group/Berkshire Hathaway Company offer this education to all physicians and healthcare providers in efforts to educate the medical and legal community on the legal issues, responsibilities and liabilities regarding the new law on medical marijuana in the State of Oklahoma.

The OSMA CME Planning Committee's intent is to keep all physicians, healthcare providers and the healthcare team informed and updated on all crucial healthcare issues facing physician practices and healthcare providers today and into the future.

This Conference will include two national speakers along with other professionals and state officials very knowledgeable and involved with this new medical marijuana law in Oklahoma. Please join us in this effort to educate the healthcare community and other professionals by attending this conference.

Target Audience

The educational design addresses the needs and issues of healthcare providers including physicians, nurses, physician assistants, healthcare administrators, legal community and the healthcare team.


“Managing Medical Marijuana: Rules, Risks and Strategies” presented by Interim Commissioner of Health Tom Bates 

8:30 a.m. to 9:45 a.m. – 1.25 AMA PRA Category 1 Credits™

[session details]


After attending the activity the physician should be able to:

  • Gain familiarity with the OMMA Program and resources available in rule; and
  • Better understanding of the background and history of the OMMA organization; and
  • Ask questions on potential future opportunities for changes.

“Don’t Get Burned: Legal Issues Associated With Medical Marijuana” presented by Cori Loomis, Esq.

9:45 a.m. to 10:45 a.m. – 1 AMA PRA Category 1 Credits™


After attending the activity the physician should be able to

  • Know the requirements of the Oklahoma medical marijuana statute and regulations; and
  • Discuss the relationship between Oklahoma and Federal laws related to marijuana and understand the inconsistencies between them; and
  • Comprehend the medical liability issues associated with recommending medical marijuana and implement policies and procedures in their practice to minimize liability; and
  • Develop an understanding of legal issues related to physicians’ roles as employer and other non-medical legal issues that may rise.

“Marijuana: The Colorado Experience” presented by Mike Van Dyke, PhD, CIH Branch Chief, Environment Epidemiology Occupational Health and Toxicology Branch including Marijuana Health Impacts

11:00 a.m. to 12:00 p.m. – 1 AMA PRA Category 1 Credits™


After attending the activity the physician should be able to

  • Describe the medical conditions for which there is high quality evidence of medical efficacy for medical marijuana; and
  • Locate and access evidence summaries and clinical guidelines related potential adverse effects of marijuana use; and
  • Identify population data useful to measure the potential public health impact of marijuana.


“Marijuana: The Nuts & Bolts You’ll Need For Providing the Licensure Card” presented by Buffy Heater, OSDH Chief of Data, Policy and Promotion

1:00 p.m. to 2:15 p.m. – 1.25 AMA PRA Category 1 Credits™


After attending the activity the physician should be able to

  • Gain familiarity with the OMMA Program and resources available; and
  • Better knowledge on physician’s and patient’s role in the licensure process; and
  • Ask specific questions of OMMA staff.

“Opioids and Marijuana: The Good, The Bad and The Ugly”  presented by Thomas C. Kupiec, PhD, President/CEO ARL BioPharma, Inc.

2:15 p.m. to 3:15 p.m. – 1 AMA PRA Category 1 Credits™


After attending the activity the physician should be able to

  • Know the effects, both good and bad, of Opioids on the individual; and
  • Learn the effects, both good and bad, of Marijuana on the individual; and
  • Describe the interaction of Marijuana and Opioids on patients taking both substances.

The Use of Cannabis in Palliative Care Patients” presented by Sunil Aggarwal, MD, PhD, FAAPMR, Physician-Scientist and Medical Geohrapher

3:30 p.m. to 4:30 p.m. – 1 AMA PRA Category 1 Credits™


After attending the activity the physician should be able to

  • Review the history of the use of cannabis in medicine; and
  • Describe the primary pharmacological actions of exogenous cannabinoids, via endocannabinoid system receptor modulation; and
  • Review key practical recommendations on the integration of cannabinoids for symptom management in palliative care patients.

Panel Discussion with all Speakers

4:30 p.m. to 5:00 p.m. – .5 AMA PRA Category 1 Credits™

Accreditation Statement

The Oklahoma State Medical Association (OSMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The OSMA designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To officially receive AMA PRA Category 1 Credits™ and a CME certificate of participation, the attendee must complete the online evaluations for each presentation attended.

Faculty and Disclosures

In accordance with ACCME requirements on disclosure, CME Planning Committee, faculty and reviewers are asked to disclose any relationships with commercial interests associated with any area of medicine featured in these activities. 

The OSMA has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the mission of the OSMA CME Planning Committee.  Conflicts, if any, are resolved through one or more processes.  All CME content in this activity was independently reviewed to ensure that it is free of commercial bias.

The OSMA Planning Committee, Faculty and Reviewers have no relevant financial relationships to disclose.  Disclosures of relevant financial relationships, if applicable, will be provided to participants prior to the presentations.


"The Oklahoma State Medical Association has been surveyed by the Accreditation Council for Continuing Medical Education (AC­CME) and awarded Accreditation with Commendation for six years as a provider of continuing medical education for physicians.

The ACCME accreditation seeks to assure the medical community and the public that the Oklahoma State Medical Association provides physicians with relevant, effective, practice-based continuing medical education that supports US health care quality improvements.

ACCMEThe ACCME employs a rigorous, multilevel process for evaluating institutions' continuing medical education programs according to the high accreditation standards adopted by all seven ACCME member organizations. These organizations of medicine in the US are the American Board of Medical Specialties, the American Hospital Association, the American Medical Association, the Association for Hospital Medical Education, the Association of American Medical Colleges, the Council of Medical Specialty Societies, and the Federation of State Medical Boards of the US, Inc."